Active-ingredient Dossier
Olmesartan Medoxomil
Active-ingredient Dossier for Olmesartan Medoxomil (angiotensin ii receptor blocker). Australian brands, products, PBS listings, PBAC outcomes — compiled…
- Brand: SEVIKAR
- Brand: OLMETEC
- Brand: AKM-OLMESARTAN HCTZ
- Brand: ALKEM
- Brand: APO-OLMESARTAN
- Brand: APO-OLMESARTAN/AMLODIPINE
- Therapeutic area: Cardiology
What is
Olmesartan Medoxomil Olmesartan medoxomil is an angiotensin II receptor blocker.
Australian brands containing
Olmesartan Medoxomil — SEVIKAR — ALKEM — APO-OLMESARTAN — APO-OLMESARTAN/AMLODIPINE — APX-OLMESARTAN — OLMERTAN — OLMESARTAN HCT VIATRIS — OLMESARTAN SANDOZ — OLMESARTAN-WGR — OLSETAN
Therapeutic areas
Olmesartan medoxomil is registered in cardiology, with 22 brands containing this ingredient on the ARTG.
Sponsor landscape
Six sponsors market olmesartan medoxomil: Arrotex Pharmaceuticals, Pharmacor, Accord Healthcare, Sandoz, GM Pharma, and Organon Pharma.
PBS and regulatory activity
The latest AusPAR for olmesartan medoxomil was published on 11 September 2013. No PBAC outcomes are on record for brands containing this ingredient.